AllovirInc Stock Buy Hold or Sell Recommendation


USD 7.58  0.07  0.93%   

Given the investment horizon of 90 days and your slightly conservative level of risk, our recommendation regarding AllovirInc is 'Strong Sell'. Macroaxis provides AllovirInc buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding ALVR positions. The advice algorithm takes into account all of AllovirInc's available fundamental, technical, and predictive indicators you will find on this site.
The advice is provided from AllovirInc's buy-and-hold perspective. Please continue to AllovirInc Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. We conduct extensive research on individual companies such as AllovirInc and provide practical buy, sell, or hold advice based on selected investing horizon and risk tolerance towards AllovirInc.

Execute AllovirInc Buy or Sell Advice

The AllovirInc recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on AllovirInc. Macroaxis does not own or have any residual interests in AllovirInc or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute AllovirInc's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell AllovirIncBuy AllovirInc
Strong Sell



Hype Condition


Current Valuation


Odds of Distress


Economic Sensitivity


Analyst Consensus


Reporting Quality (M-Score)

For the selected time horizon AllovirInc has a Mean Deviation of 4.41, Semi Deviation of 4.99, Standard Deviation of 6.07, Variance of 36.88, Downside Variance of 28.02 and Semi Variance of 24.85
We provide trade advice to complement the prevailing expert consensus on AllovirInc. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure AllovirInc is not overpriced, please confirm all AllovirInc fundamentals, including its book value per share, and the relationship between the net income and number of employees . Given that AllovirInc has a gross profit of 165 K, we suggest you to validate AllovirInc market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.

AllovirInc Trading Alerts and Improvement Suggestions

AllovirInc has very high historical volatility over the last 90 days
Net Loss for the year was (171.96 M) with profit before overhead, payroll, taxes, and interest of 165 K.
AllovirInc currently holds about 172.67 M in cash with (106.32 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.91.
Roughly 50.0% of the company shares are held by company insiders

AllovirInc Returns Distribution Density

The distribution of AllovirInc's historical returns is an attempt to chart the uncertainty of AllovirInc's future price movements. The chart of the probability distribution of AllovirInc stock daily returns describes the distribution of returns around its average expected value. We use AllovirInc price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of AllovirInc returns is essential to provide solid investment advice for AllovirInc.
Mean Return0.21Value At Risk-8.21
Potential Upside13.47Standard Deviation6.07
   Return Density   
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of AllovirInc historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

AllovirInc Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as AllovirInc is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading AllovirInc backward and forwards among themselves. AllovirInc's institutional investor refers to the entity that pools money to purchase AllovirInc's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Zurcher Kantonalbank Zurich CantonalbankCommon Shares1.3 K17 K
Zurcher Kantonalbank Zurich CantonalbankCommon Shares1.5 K37 K
Zurcher Kantonalbank Zurich CantonalbankCommon Shares1.5 K29 K
Zurcher Kantonalbank Zurich CantonalbankCommon Shares1.4 K32 K
Zimmer Partners LpCommon Shares25 K688 K
Xtx Topco LtdCommon Shares16 K126 K
Xtx Topco LtdCommon Shares12.8 K50 K
Note, although AllovirInc's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

AllovirInc Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to AllovirInc or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that AllovirInc's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a AllovirInc stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Alpha over NYSE Composite
Beta against NYSE Composite1.62
Overall volatility
Information ratio 0.0226

AllovirInc Volatility Alert

AllovirInc is displaying above-average volatility over the selected time horizon. Investors should scrutinize AllovirInc independently to ensure intended market timing strategies are aligned with expectations about AllovirInc volatility. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure AllovirInc's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact AllovirInc's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

AllovirInc Fundamentals Vs Peers

Comparing AllovirInc's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze AllovirInc's direct or indirect competition across all of the common fundamentals between AllovirInc and the related equities. This way, we can detect undervalued stocks with similar characteristics as AllovirInc or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of AllovirInc's fundamental indicators could also be used in its relative valuation, which is a method of valuing AllovirInc by comparing valuation metrics with those of similar companies.
 Better Than Average     
 Worse Than Average Compare AllovirInc to competition
FundamentalsAllovirIncPeer Average
Return On Equity(0.72) %(0.31) %
Return On Asset(0.38) %(0.14) %
Current Valuation441.38 M16.62 B
Shares Outstanding93.16 M571.82 M
Shares Owned by Insiders49.88 %10.09 %
Shares Owned by Institutions40.37 %39.21 %
Number of Shares Shorted4.27 M4.71 M
Price to Book2.70 X9.51 X
Gross Profit165 K27.38 B
EBITDA(170.77 M)3.9 B
Net Income(171.96 M)570.98 M
Cash and Equivalents172.67 M2.7 B
Cash per Share1.91 X5.01 X
Total Debt22.51 M5.32 B
Debt to Equity0.14 %48.70 %
Current Ratio8.18 X2.16 X
Book Value Per Share2.82 X1.93 K
Cash Flow from Operations(106.32 M)971.22 M
Short Ratio13.00 X4.00 X
Earnings Per Share(2.92) X3.12 X
Price to Earnings To Growth(0.06) X4.89 X
Target Price26.25
Number of Employees10718.84 K
Market Capitalization667.98 M19.03 B
Total Asset286.59 M29.47 B
Retained Earnings(388.9 M)9.33 B
Working Capital8.4 M1.48 B
Current Asset61.62 M9.34 B
Current Liabilities53.23 M7.9 B
Z Score3.78.72
Net Asset286.59 M
   Sale by Van Beek Jeroen B of 16074 shares of AllovirInc [view details]

AllovirInc Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as AllovirInc . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About AllovirInc Buy or Sell Advice

When is the right time to buy or sell AllovirInc? Buying financial instruments such as AllovirInc Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having AllovirInc in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Real Estate Thematic Idea Now

Real Estate
Real Estate Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Real Estate theme has 4 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Real Estate Theme or any other thematic opportunities.
View All  Next Launch
Please continue to AllovirInc Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Complementary Tools for analysis

When running AllovirInc price analysis, check to measure AllovirInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AllovirInc is operating at the current time. Most of AllovirInc's value examination focuses on studying past and present price action to predict the probability of AllovirInc's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move AllovirInc's price. Additionally, you may evaluate how the addition of AllovirInc to your portfolios can decrease your overall portfolio volatility.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Is AllovirInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AllovirInc. If investors know AllovirInc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AllovirInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
668 M
Return On Assets
Return On Equity
The market value of AllovirInc is measured differently than its book value, which is the value of AllovirInc that is recorded on the company's balance sheet. Investors also form their own opinion of AllovirInc's value that differs from its market value or its book value, called intrinsic value, which is AllovirInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AllovirInc's market value can be influenced by many factors that don't directly affect AllovirInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AllovirInc's value and its price as these two are different measures arrived at by different means. Investors typically determine AllovirInc value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AllovirInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.